Adaptive Biotechnologies Corp. (ADPT)
24.39
-0.53
(-2.13%)
USD |
NASDAQ |
Sep 01, 11:12
Adaptive Biotechnologies Cash and Short Term Investments (Quarterly) : 344.26M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 344.26M |
| March 31, 2026 | 218.33M |
| December 31, 2025 | 226.98M |
| September 30, 2025 | 212.77M |
| June 30, 2025 | 197.87M |
| March 31, 2025 | 193.42M |
| December 31, 2024 | 222.29M |
| September 30, 2024 | 243.33M |
| June 30, 2024 | 291.88M |
| March 31, 2024 | 308.87M |
| December 31, 2023 | 346.40M |
| September 30, 2023 | 371.13M |
| June 30, 2023 | 417.23M |
| March 31, 2023 | 440.70M |
| December 31, 2022 | 498.20M |
| Date | Value |
|---|---|
| September 30, 2022 | 508.08M |
| June 30, 2022 | 383.74M |
| March 31, 2022 | 363.56M |
| December 31, 2021 | 353.06M |
| September 30, 2021 | 415.04M |
| June 30, 2021 | 598.41M |
| March 31, 2021 | 714.26M |
| December 31, 2020 | 688.27M |
| September 30, 2020 | 835.08M |
| June 30, 2020 | 570.38M |
| March 31, 2020 | 555.17M |
| December 31, 2019 | 576.87M |
| September 30, 2019 | 573.43M |
| June 30, 2019 | 423.00M |
| March 31, 2019 | 440.43M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Personalis, Inc. | 212.66M |
| 10X Genomics, Inc. | 552.03M |
| Alamar Biosciences, Inc. (California) | 250.05M |
| Champions Oncology, Inc. | 4.872M |
| Medpace Holdings, Inc. | 502.69M |